CorMedix Granted Extension of NYSE MKT Listing

[Business Wire] – CorMedix Inc. , a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal more

View todays social media effects on CRMD

View the latest stocks trending across Twitter. Click to view dashboard

See who CorMedix is hiring next, click here to view